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INTRODUCTION
Clear cell sarcoma (CCS) was first described by Enzinger in 1965. It is a rare, aggressive, soft-tissue tumor constituting approximately 1% of all soft-tissue sarcomas. Due to its close clinical and histological similarity with malignant melanoma, Chung and Enzinger proposed the name "malignant melanoma of soft parts." [1] It is known to occur mainly in the soft tissues and dermis. [2] CCS of tendons and aponeuroses is a rare, high-grade malignant soft-tissue tumor.
CASE REPORT
A 5-year-old boy presented with swelling over the left back for 1 month. The swelling was sudden in onset and gradually progressive in nature. It was very tender and was located 5 cm lateral to the thoracic spine. There was no history of fever. The pain subsided on taking medication. His hematological, coagulation, and biochemical profiles were within normal limits. On examination, the swelling measured 6 cm × 6 cm, was tender and immobile. Clinically, it was diagnosed as an abscess. X-ray revealed a soft-tissue mass with normal underlying bone. Ultrasonography showed a subcutaneous heterogenous collection with internal echoes. Pus was seen in the in the paraspinal ligament of paravertebral region. Peroperatively, it turned out to be solid, giving a clinical impression of sarcoma. Hematoxylin and eosin (H and E)-stained sections of the excised tissue showed the absence of an epithelial covering [ Figure 1a ]. Clusters of fusiform cells [ Figure 1b ] were present that were separated by a thin fibrovascular septa [ Figure 1c ]. The individual cells were large with pleomorphic, vesicular nuclei, prominent 1-2 basophilic nucleoli, and clear cytoplasm [ Figure 1d ]. Mitoses were frequent, approximately 2-3/10 hpf. Apoptotic bodies and areas of necrosis were observed. Few multinucleated giant cells were present. However, no obvious pigmentation could be identified. Immunohistochemistry (IHC) revealed positivity for pancytokeratin [ Figure 2a ], epithelial membrane antigen [ Figure 2b ], vimentin [ Figure 2c ], and melan A [ Figure 2d ], with focal immunopositivity for HMB 45 [ Figure 2e ]; while chromogranin, synaptophysin, S-100 protein, desmin, and smooth muscle antigen were immunonegative. Staining for Ki67 showed a proliferation index of around 70% [ Figure 2f ]. Based on the histological and immunohistochemical profile, a diagnosis of CCS was offered. 
DISCUSSION
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Majority of the cases of CCS have been observed in the 20-40 age group, with mean age of 27 years [3] and having a predilection for female patients. In this regards, the present case was unique because it presented in a young male child. It originates from tendons, aponeuroses, and fascial structures of the extremities with a predilection for the feet and knees. CCS presents as an insidiously growing lump or hard mass causing pain or tenderness.
CCS is characterized by a recurrent chromosomal translocation t (12; 22), which results in fusion of the EWS gene on 22q with the ATF1 gene on 12q. [8] It has been associated with both EWSR1-ATF1 and EWSR1-CREB1 fusion transcripts. [9] The exact histogenesis remains obscure, but the presence of intracellular melanin in two-third of the cases supports origin from migrated cells of neural crest. [3, 9] For this reason, the term malignant melanoma of soft part seems preferable over the purely descriptive term of CCS. The reciprocal translocation t (12; 22) (q13; q12) is observed in more than 90% of CCS cases along with polysomy of chromosome 8 as a secondary abnormality in many cases. [8, 9] Differentiation of CCS from other close differentials often requires correlation with clinical, histological, and molecular findings. Main differentials include tumors such as metastatic malignant melanoma, malignant cellular blue nevus, malignant peripheral nerve sheath tumor, paraganglioma-like dermal melanocytic tumors and nonmelanotic tumors such as perivascular epithelioid cell tumor (PEComas), epithelioid leiomyosarcoma, fibrosarcoma, alveolar soft-part sarcoma, monophasic synovial sarcoma, and renal cell carcinoma. [1, 10] CCS can involve any ligament, tendon, or aponeurosis. Thus, radiological and histopathological evaluation aided by an appropriate panel of IHC markers is imperative for proper diagnosis. Because of their typical histologic picture and their particular clinical behavior, they should be regarded as a definite clinicopathological entity. Imaging studies such as X-rays, computed tomography (CT) scans or magnetic resonance imaging (MRI) may be required for diagnosis. Chest CT, bone scan, and positron emission tomography are often required to assess metastases. MRI typically shows a benign-looking, well-defined, homogenous mass; on T1-weighted MR images, it is usually homogeneous and isointense or slight hyperintense to muscles, whereas on T2-weighted MR images, it is usually more heterogeneous with variable signal intensity. [4] Diagnosis of CCS can be challenging. Histologically, it shows compact nests or fascicles of predominantly fusiform or spindled cells with a clear to granular cytoplasm surrounded by a delicate framework of fibrocollagenous tissue contiguous with the adjacent tendons or aponeuroses. The cells have highly distinctive features consisting of vesicular nuclei and prominent basophilic nucleoli reminiscent of malignant melanoma. [1] The histologic features of cellular arrangement in nest, cluster or "ball"-like formations and a prominent nucleolus are the most reliable diagnostic patterns. The cytoplasm varies from being clear to weakly eosinophilic and contains a large amount of intracellular glycogen giving it the clear cell appearance. More than 50% of case contains multinucleate (wreath-type) giant cells. Approximately, two-thirds of the tumors contain a variable amount of melanin pigment demonstrable on H and E or, using special stains. The cells show absent or minimal pleomorphism and very few mitotic figures indicating its slow-growing nature. Areas of necrosis may be present. CCS such as melanoma, shows Tumor size more than 5 cm and necrosis are indicators of poor prognosis. Age, location, depth, or proliferation index are independent prognostic factors. Metastasis occurs in more than half of the cases and usually to the bones, lymph node, and lungs with 5-year survival rates of 50%-65%. [3] Recurrence is a common feature. [2] Treatment depends on the site and the extent of the disease. Radical surgery is the mainstay of therapy with chemotherapy used in metastasis. Use of standard sarcoma regimens has not been successful, while interferon-alpha 2 B has been reported to have some role. [10] CONCLUSION CCS should be considered in the differential diagnosis of paraspinal masses. Confirmed diagnosis requires histopathology and IHC marker panel. Complete surgical excision with radiotherapy is the mainstay of treatment.
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